I was trying to do some rough calculations on a possible deal for Humira (all numbers rounded).
This drug sells at about 2000$ per unit and has annual revenues of 10 billion $.
This makes up for 5 million units a year.
At about 1$ pricing vor the Unifill this would result in only 5 million $ per year to Unilife.
According to my information Humira has to be injected every two weeks. This equates to ~190000 patients worldwide. I don't know the pricing of the Lisa Auto injector but as this is a more or less non recurring revenue (not accounting for new patients) and using 30$ per unit it would only result in ~ 6 million $ to Unilife.
Adding to this any exclusivity deal will of course improve the economics.
I got the impression that I am missing something essential but for now I am far more impressed by the Sanofi deal.
Anybody care to "improve" my calculations?
Cheers
UNS Price at posting:
85.5¢ Sentiment: Hold Disclosure: Held
